NewYork-Presbyterian Hospital:企業の戦略的SWOT分析

◆英語タイトル:NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review
◆商品コード:DATA904C12708
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:政府系・NPO
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NewYork-Presbyterian Hospital – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

NewYork- Presbyterian Hospital (NYPH) is a not-for-profit medical center, providing a wide range of health care services to the residents of the New York. It operates through a network of hospitals and medical centers. Its service portfolio includes a wide range of medical, surgical, and emergency care services in the therapeutic areas of cancer, children’s health, geriatrics, heart, orthopedics, neuroscience, psychiatry, transplantation and women’s health, among others. The hospital also offers clinical and medical research, medical education and community services in affiliation with two medical colleges, namely, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons. The hospital was formed as a result of the merger between The New York Hospital and The Presbyterian Hospital. NYPH is headquartered in New York, the US.

NewYork-Presbyterian Hospital Key Recent Developments

May 10,2018: Dr. Katherine L. Heilpern Named Senior Vice President and Chief Operating Officer at NewYork-Presbyterian/Weill Cornell Medical Center
Apr 24,2018: NewYork-Presbyterian Opens A World-Class Center For Ambulatory Care: NewYork-Presbyterian David H. Koch Center
Dec 07,2017: Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors
Nov 16,2017: Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care
Aug 02,2017: Dr. Laureen Hill named senior vice president and chief operating officer

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
NewYork-Presbyterian Hospital – Key Facts 5
NewYork-Presbyterian Hospital – Key Employees 6
NewYork-Presbyterian Hospital – Key Employee Biographies 9
NewYork-Presbyterian Hospital – Major Products and Services 12
NewYork-Presbyterian Hospital – History 13
NewYork-Presbyterian Hospital – Company Statement 17
NewYork-Presbyterian Hospital – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2 – Company Analysis 20
Company Overview 20
NewYork-Presbyterian Hospital – Business Description 21
R&D Overview 21
NewYork-Presbyterian Hospital – Corporate Strategy 22
NewYork-Presbyterian Hospital – SWOT Analysis 23
SWOT Analysis – Overview 23
NewYork-Presbyterian Hospital – Strengths 23
NewYork-Presbyterian Hospital – Weaknesses 24
NewYork-Presbyterian Hospital – Opportunities 25
NewYork-Presbyterian Hospital – Threats 26
NewYork-Presbyterian Hospital – Key Competitors 27
NewYork-Presbyterian Hospital, Recent Deals Summary 28
Section 3 – Company’s Recent Developments 29
May 10, 2018: Dr. Katherine L. Heilpern Named Senior Vice President and Chief Operating Officer at NewYork-Presbyterian/Weill Cornell Medical Center 29
Apr 24, 2018: NewYork-Presbyterian Opens A World-Class Center For Ambulatory Care: NewYork-Presbyterian David H. Koch Center 31
Dec 07, 2017: Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors 33
Nov 16, 2017: Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care 35
Section 4 – Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
NewYork-Presbyterian Hospital, Key Facts 5
NewYork-Presbyterian Hospital, Key Employees 6
NewYork-Presbyterian Hospital, Key Employee Biographies 9
NewYork-Presbyterian Hospital, Major Products and Services 12
NewYork-Presbyterian Hospital, History 13
NewYork-Presbyterian Hospital, Other Locations 18
NewYork-Presbyterian Hospital, Subsidiaries 19
NewYork-Presbyterian Hospital, Key Competitors 27
NewYork-Presbyterian Hospital, Recent Deals Summary 28

★海外企業調査レポート[NewYork-Presbyterian Hospital:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioqual Inc (BIOQ):企業の財務・戦略的SWOT分析
    Summary Bioqual Inc (Bioqual) is a provider of contract research services which focuses on in vivo models of human diseases such as AIDS, influenza, RSV infection flavivirus infections including zika and dengue, malaria, hepatitis and cancer. The company evaluates vaccines, vaccine therapeutics, mic …
  • Ballard Power Systems Inc. (BLDP)-エネルギー分野:企業M&A・提携分析
    Summary Ballard Power Systems Inc. (Ballard Power) is a renewable energy company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines i …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • pSivida Corp (PSDV):製品パイプライン分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • Boise Cascade Co (BCC):企業の財務・戦略的SWOT分析
    Summary Boise Cascade Co (Boise Cascade) is engaged in the manufacture and distributor of wood products and building materials. The company's product portfolio include engineered wood, panels and lumber and building materials. Its building materials comprise concrete products, adhesive, gypsum, insu …
  • Crossject SA (ALCJ):医療機器:M&Aディール及び事業提携情報
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • Turner Construction Co:企業の戦略的SWOT分析
    Turner Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Elsalys Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The company's pipeline programs include anti-CD160, for macular degeneration or certain retinopathie …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Autotelic Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Autotelic Inc (Autotelic) is a therapeutic drug monitoring company that develops novel treatments using its therapeutic drug monitoring (TDM) services. The company's pipeline products include devices to improve safety and efficacy of COX-2 inhibitors, paclitaxel nanomedicine, TGF-beta inhibi …
  • Krka dd Novo Mesto (KRKG):企業の財務・戦略的SWOT分析
    Summary Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and meta …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Manulife Financial Corporation:企業のM&A・事業提携・投資動向
    Manulife Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Manulife Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Senvion SA:企業の戦略的SWOT分析
    Senvion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Shell Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Shell Canada Ltd (Shell Canada) a subsidiary of Royal Dutch Shell plc is an integrated oil and gas company that offers upstream and downstream services. The company's upstream services include markets and trades natural gas and power and exploration and extraction of natural gas. Its downstr …
  • Datron World Communications, Inc.:企業の戦略・SWOT・財務情報
    Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pakistan Oilfields Ltd (POL):企業の財務・戦略的SWOT分析
    Pakistan Oilfields Ltd (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ChemDiv Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ChemDiv Inc (ChemDiv) a subsidiary of ChemRar High-Tech Center is a contract research organization that offers chemistry services, hit finding, integrated drug discovery, pharmatech services, disease based models, drug development, and others. The organization also offers chemistry building …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆